These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 26164382)

  • 1. Prognostic value of cytokeratin 19 in hepatocellular carcinoma: A meta-analysis.
    Sun DW; Zhang YY; Sun XD; Chen YG; Qiu W; Ji M; Lv GY
    Clin Chim Acta; 2015 Aug; 448():161-9. PubMed ID: 26164382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Prognostic Significance of NEK2 in Hepatocellular Carcinoma: Evidence from a Meta-Analysis and Retrospective Cohort Study.
    Cheng Y; Chen X; Ye L; Zhang Y; Liang J; Liu W; Zhou B; Zheng S; Huang Y; Chen G; Deng Y; Zhang Q; Yang Y
    Cell Physiol Biochem; 2018; 51(6):2746-2759. PubMed ID: 30562736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of parameters from pretreatment (18)F-FDG PET in hepatocellular carcinoma: a meta-analysis.
    Sun DW; An L; Wei F; Mu L; Shi XJ; Wang CL; Zhao ZW; Li TF; Lv GY
    Abdom Radiol (NY); 2016 Jan; 41(1):33-41. PubMed ID: 26830609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigation of the value of miR-21 in the diagnosis of early stage HCC and its prognosis: a meta-analysis.
    Yan SR; Liu ZJ; Yu S; Bao YX
    Genet Mol Res; 2015 Sep; 14(3):11573-86. PubMed ID: 26436398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic and clinicopathological value of Nanog in hepatocellular carcinoma: A meta-analysis.
    Liang C; Zhang K; Ge H; Li W; Li G; Wu J
    Clin Chim Acta; 2018 Feb; 477():24-31. PubMed ID: 29198990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytokeratin 10 and cytokeratin 19: predictive markers for poor prognosis in hepatocellular carcinoma patients after curative resection.
    Yang XR; Xu Y; Shi GM; Fan J; Zhou J; Ji Y; Sun HC; Qiu SJ; Yu B; Gao Q; He YZ; Qin WZ; Chen RX; Yang GH; Wu B; Lu Q; Wu ZQ; Tang ZY
    Clin Cancer Res; 2008 Jun; 14(12):3850-9. PubMed ID: 18559605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic and clinicopathological significance of MACC1 expression in hepatocellular carcinoma patients: a meta-analysis.
    Sun DW; Zhang YY; Qi Y; Liu GQ; Chen YG; Ma J; Lv GY
    Int J Clin Exp Med; 2015; 8(4):4769-77. PubMed ID: 26131051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of MMP-7 expression in colorectal cancer: a meta-analysis.
    Sun DW; Zhang YY; Qi Y; Zhou XT; Lv GY
    Cancer Epidemiol; 2015 Apr; 39(2):135-42. PubMed ID: 25677090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic and clinicopathological significance of glypican-3 overexpression in hepatocellular carcinoma: a meta-analysis.
    Li J; Gao JZ; Du JL; Wei LX
    World J Gastroenterol; 2014 May; 20(20):6336-44. PubMed ID: 24876756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic and diagnostic significance of circRNAs expression in hepatocellular carcinoma patients: A meta-analysis.
    Huang X; Zhang W; Shao Z
    Cancer Med; 2019 Mar; 8(3):1148-1156. PubMed ID: 30693679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Meta-analysis of the prognostic and diagnostic significance of serum/plasma osteopontin in hepatocellular carcinoma.
    Cheng J; Wang W; Sun C; Li M; Wang B; Lv Y
    J Clin Gastroenterol; 2014 Oct; 48(9):806-14. PubMed ID: 24247813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High TGF-β1 expression predicts poor disease prognosis in hepatocellular carcinoma patients.
    Peng L; Yuan XQ; Zhang CY; Ye F; Zhou HF; Li WL; Liu ZY; Zhang YQ; Pan X; Li GC
    Oncotarget; 2017 May; 8(21):34387-34397. PubMed ID: 28415739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modified Glasgow prognostic score might be a prognostic factor for hepatocellular carcinoma: a meta-analysis.
    Chen H; Hu N; Chang P; Kang T; Han S; Lu Y; Li M
    Panminerva Med; 2017 Dec; 59(4):302-307. PubMed ID: 28001023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of cytokeratin 19 expression in pancreatic neuroendocrine tumor: A meta-analysis.
    Cen D; Chen J; Li Z; Zhao J; Cai X
    PLoS One; 2017; 12(11):e0187588. PubMed ID: 29136022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FIB-4 index serves as a noninvasive prognostic biomarker in patients with hepatocellular carcinoma: A meta-analysis.
    Zhang Y; Wang R; Yang X
    Medicine (Baltimore); 2018 Dec; 97(51):e13696. PubMed ID: 30572498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Meta-Analysis of the Prognostic and Clinical Value of Tumor-Associated Macrophages in Hepatocellular Carcinoma.
    Zhang J; Chang L; Zhang X; Zhou Z; Gao Y
    J Invest Surg; 2021 Mar; 34(3):297-306. PubMed ID: 31412745
    [No Abstract]   [Full Text] [Related]  

  • 17. CD147 as a Novel Prognostic Biomarker for Hepatocellular Carcinoma: A Meta-Analysis.
    Peng F; Li H; You Q; Li H; Wu D; Jiang C; Deng G; Li Y; Li Y; Wu Y
    Biomed Res Int; 2017; 2017():5019367. PubMed ID: 28386553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis.
    Lu LL; Sun J; Lai JJ; Jiang Y; Bai LH; Zhang LD
    World J Gastroenterol; 2015 Jun; 21(21):6649-59. PubMed ID: 26074703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of E-cadherin expression in hepatocellular carcinoma: a meta-analysis.
    Chen J; Zhao J; Ma R; Lin H; Liang X; Cai X
    PLoS One; 2014; 9(8):e103952. PubMed ID: 25093414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic Value of Lactate Dehydrogenase in Patients with Hepatocellular Carcinoma: A Meta-Analysis.
    Kong W; Zuo X; Liang H; Hu J; Zhang H; Wang X; Chen W
    Biomed Res Int; 2018; 2018():1723184. PubMed ID: 30687735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.